1,916 material Form 8-K filings that 1,609 companies we cover made with the SEC in July 2026, each read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). All of them were written later, when past filings were added: a selection, not every 8-K of the month (see the note below).
Ares Acquisition Corporation III, a blank check company, completed its initial public offering on July 1, 2026, selling 39,500,000 units at $10.00 each for gross proceeds of $395 million, including 5,000,000 units from partial exercise of the underwriters' over-allotment option. A total of $406.2 million, including $11.2 million from the sponsor's private placement of warrants, was deposited into a trust account, which generally cannot be released until a business combination, a shareholder vote on charter changes, or a redemption of public shares.
IPO of 39,500,000 units at $10.00 per unit on July 1, 2026, generating gross proceeds of $395 million
Sponsor purchased 7,466,667 private placement warrants at $1.50 each, for $11.2 million
$406.2 million placed in trust account at JPMorgan Chase Bank, with Continental Stock Transfer & Trust Company as trustee
Public warrants exercisable at $11.50 per share; sponsor office and administrative fee is $16,667 per month
Mobility Global Inc. became an independent, publicly traded company on July 1, 2026, after S&P Global distributed 100% of its shares to S&P Global stockholders. The separation matters to shareholders because S&P Global retains no ownership in Mobility Global, and the company now operates under agreements with S&P Global covering taxes, transition services, and employees.
Distribution ratio: one Mobility Global share for every S&P Global share held at close of business on June 15, 2026
Separation effective 12:01 a.m. New York City time on July 1, 2026; shares trade on the NYSE under MBGL
Transition services from S&P Global may run up to 18 months; Mobility Global may terminate them on prior written notice
Tax Matters Agreement restricts certain actions for two years after the Distribution Date to preserve tax-free treatment
S&P Global completed the separation of its Mobility division on July 1, 2026, distributing 100% of Mobility Global Inc. common stock to S&P Global stockholders. S&P Global retains no ownership interest in Mobility Global, which is now an independent company listed on the New York Stock Exchange under MBGL. The filing sets out agreements covering the separation, taxes, transition services and employees, and the company plans to issue recast 2025 and first-quarter 2026 financial information on July 6, 2026.
Distribution Date was July 1, 2026, effective at 12:01 a.m. New York City time.
Stockholders of record on June 15, 2026 received one share of Mobility Global common stock for every S&P Global share held.
Transition services from S&P Global to Mobility Global are generally available for up to 18 months after the Distribution.
Mobility Global faces restrictions on certain actions for two years after the Distribution Date to preserve tax-free treatment.
Neurogene agreed on June 30, 2026 to sell 3,500,000 common shares at $30.00 each, with pre-funded warrants for up to 666,666 more shares offered in place of common stock for some investors. Underwriters exercised in full their option to buy 624,999 additional shares on July 1, 2026, and the company expects net proceeds of about $134.8 million. The company says these proceeds, plus existing cash, will fund operations into the first quarter of 2029, but the sale adds new shares outstanding for existing shareholders.
3,500,000 common shares offered at $30.00 per share, plus pre-funded warrants for up to 666,666 shares
Underwriters exercised in full their option for up to 624,999 additional shares on July 1, 2026
Expected net proceeds of approximately $134.8 million after underwriting discounts and estimated expenses
Offering expected to close July 2, 2026; company expects cash to last into the first quarter of 2029
On June 30, 2026, Jackson Financial entered a revolving credit agreement with aggregate commitments of $1.25 billion, led by Wells Fargo as administrative agent. The new agreement replaces the company's $1 billion 2023 credit facility, which was scheduled to terminate in February 2028, and the filing describes its covenants as substantially similar to that earlier agreement.
Aggregate commitments of $1.25 billion, with a $500 million sub-limit for letters of credit and a possible increase of up to $500 million on request
Replaces the $1 billion credit agreement dated February 24, 2023, which was scheduled to terminate in February 2028
Commitments terminate June 30, 2031, with two one-year extension options subject to required bank approval
Borrowings are unsecured, priced at Term SOFR plus 1.125% to 1.875% or Base Rate plus 0.125% to 0.875%, based on the company's senior debt ratings
Whirlpool announced on July 1, 2026 that it will close its Supsa manufacturing facility in Apodaca, Mexico, by the second quarter of 2027, moving production to its Ramos Arizpe, Mexico plant and across its supply chain. The company estimates $165 million in total restructuring costs, with about $70 million expected to be cash expenditures, so shareholders face a large charge now while the filing does not quantify the expected savings.
Supsa facility in Apodaca, Mexico to close by the second quarter of 2027, with production shifted to Ramos Arizpe, Mexico
Estimated total restructuring costs of $165 million: up to $95 million asset impairment, $30 million employee-related, and $40 million other
About $100 million of the $165 million expected in 2026; about $70 million total cash expenditures, with $15 million expected in 2026
Actions expected to be substantially complete in 2027
Hims & Hers subsidiaries XeCare LLC and Apostrophe Pharmacy LLC entered a Master Receivables Purchase Agreement with JPMorgan Chase Bank on July 1, 2026, allowing them to sell eligible receivables for cash, subject to a $400 million facility limit. The company also agreed to guarantee the sellers' performance under the agreement, though not the collectability of the receivables, and amended its credit agreement to permit the arrangement.
Facility limit for eligible receivables is $400 million, with an initial term of 364 days that may be extended.
The company guarantees the sellers' performance under the agreement but not receivable collectability or seller creditworthiness.
Amendment No. 4 to the Revolving Credit and Guaranty Agreement, dated June 26, 2026, adds a $400 million debt basket for this arrangement.
The filing does not disclose the purchase discount or any financial results tied to the arrangement.
Compass Therapeutics furnished an updated corporate presentation dated July 2026 that includes data from its COMPANION-002 study of tovecimig plus paclitaxel in biliary tract cancer. The study met its primary endpoint of overall response rate (18.0% vs 5.3%) and showed a longer median progression-free survival (4.7 vs 2.6 months), but overall survival was not significantly different (8.9 vs 9.4 months) because of crossover.
Primary endpoint overall response rate was 18.0% for tovecimig plus paclitaxel vs 5.3% for paclitaxel alone (p=0.0228)
Median progression-free survival was 4.7 vs 2.6 months (HR=0.44, p<0.0001); median overall survival was 8.9 vs 9.4 months (HR=1.05, p=0.78)
Company plans an FDA meeting in Q3 2026 and a BLA filing in Q4 2026, with potential approval in 2027
Company reported $195 million in cash and marketable securities at Q1 2026, with runway into 2028
Apogee Enterprises completed its acquisition of Keller Companies, Inc., including Kalwall Corporation and Structures Unlimited, on July 1, 2026. The company paid $105 million in cash at closing, with up to an additional $10 million of contingent consideration tied to the acquired businesses' future performance. The deal was funded with available cash and borrowings under the existing revolving credit facility.
Base purchase price of $105 million paid at closing, subject to customary post-closing adjustments
Up to $10 million of additional contingent consideration based on future financial performance of the acquired companies
Funded with available cash and borrowings under the existing revolving credit facility
Merger Agreement dated May 27, 2026 was previously reported in an 8-K filed May 28, 2026
Aon's board approved an additional $7.5 billion share repurchase authorization on June 26, 2026, on top of about $0.8 billion remaining under the existing program as of March 31, 2026. At the same meeting, shareholders did not approve the advisory vote on executive compensation, while all 13 director nominees were elected.
Board approved an additional $7.5 billion repurchase authorization on June 26, 2026; the program does not obligate Aon to buy any particular amount of shares.
Existing program had about $0.8 billion of remaining authorization as of March 31, 2026.
Advisory say-on-pay vote failed: 69,888,299 for, 110,798,636 against, 1,112,848 abstain.
All 13 director nominees were elected at the June 26, 2026 Annual Meeting, including Lester B. Knight and Gregory C. Case.
Nasdaq, Inc. entered into an amended and restated credit agreement on June 30, 2026, providing a $1.5 billion senior unsecured five-year revolving credit facility that replaces its existing 2022 credit agreement as amended. As of July 1, 2026, no loans were outstanding, and the facility matures on June 30, 2031, so the filing mainly refinances existing borrowing capacity rather than adding new debt today.
On June 25, 2026, Six Flags amended the employment agreement of Chief Operating Officer Tim Fisher. The amendment sets the agreement's term to expire on December 15, 2026, and extends certain benefits through that date to retain him. Mr. Fisher agreed not to receive a 2026 annual equity grant or retention bonus under the agreement.
Amendment entered into June 25, 2026, covering the employment agreement of COO Tim Fisher
Agreement term will expire December 15, 2026
Certain benefits extended through December 15, 2026 to retain Mr. Fisher
Mr. Fisher will not receive a 2026 annual equity grant or retention bonus payment under the agreement
NHC completed its purchase of the real estate of 32 skilled nursing facilities and 3 independent living facilities from National Health Investors for $560 million, ending a lease arrangement under which NHC had operated these facilities since a 1991 master lease. The company said it expects the ownership to be accretive to earnings and cash flow, but the filing gives no figures for that expectation. The deal was funded with $530 million of new borrowings, which adds to NHC's debt.
Purchase price of $560 million for real estate of 35 facilities (32 skilled nursing, 3 independent living), located in seven states
Drew the entire $475 million senior unsecured term loan and $55 million under the revolving credit facility on the closing date
Revolving credit facility increased from $50 million to $75 million under a First Amendment dated June 29, 2026; prior $50 million facility terminated with no outstanding borrowings
Four Florida skilled nursing facilities remain subject to a third-party operator's lease, which NHC has assumed under a subsidiary
Jade Biosciences entered into a license agreement with Paragon Therapeutics on June 29, 2026, granting it exclusive worldwide rights to certain monospecific antibodies and products targeting an undisclosed target. The company must pay Paragon milestone payments of up to $22.0 million, sublicensing fees of up to approximately $20.1 million, and royalties on net sales, which shows the financial commitments tied to the program.
Agreement dated June 29, 2026; Jade already paid a $1.5 million candidate nomination fee in January 2026.
Milestones total up to $22.0 million, including a $2.5 million payment upon first human dosing in a Phase 1 trial.
Royalties of low to mid-single-digit percentage on monospecific product sales and mid-single-digit on multispecific product sales.
Paragon will not run new campaigns generating monospecific antibodies against the Target for at least five years; full text to be filed with the 10-Q for the quarter ending June 30, 2026.
Kohl's amended its revolving credit facility with Wells Fargo Bank as agent on June 30, 2026, extending the maturity by five years to June 30, 2031. The amendment also changes borrowing costs and borrowing base terms, including a new in-transit inventory basket capped at 15% of the borrowing base.
Maturity extended five years from the effective date of the amendment to June 30, 2031
Applicable Margin now ranges from 0.25% to 0.50% for Base Rate Loans and 1.25% to 1.50% for SOFR Loans, using a single 50% availability breakpoint
Removed the prior 0.10% credit spread adjustment from Term SOFR; in-transit inventory may count up to 15% of the borrowing base
Culp reported fourth-quarter fiscal 2026 net sales of $51.6 million, up 5.8% from a year earlier, but its net loss widened slightly to $2.2 million, or $0.18 per diluted share, from $2.1 million, or $0.17 per share. For the full year ended May 3, 2026, sales fell 4.6% to $203.5 million while the net loss narrowed to $10.2 million, or $0.81 per share, from $19.1 million. The company expects to recover about $7.0 million in IEEPA tariff refunds in the first quarter of fiscal 2027, which it says should reduce net debt to about $5.0 million at that quarter-end.
Q4 net sales $51.6 million, up 5.8% from $48.8 million a year earlier; gross profit fell to $6.8 million from $7.7 million
Q4 net loss $2.2 million, or $0.18 per diluted share, versus $2.1 million, or $0.17, in the prior-year quarter
Full-year net loss $10.2 million, or $0.81 per share, versus $19.1 million, or $1.53, in fiscal 2025
Outlook: about $7.0 million in IEEPA tariff refunds expected in Q1 fiscal 2027; net debt expected near $5.0 million at quarter-end
National Health Investors completed the sale of 35 facilities, including 32 skilled nursing facilities and three independent living facilities, to subsidiaries of National HealthCare Corporation (NHC) for a total purchase price of $560 million, effective July 1, 2026. The Master Lease was terminated for all facilities except four Florida skilled nursing facilities, which were assigned to an NHC subsidiary. NHC is a shareholder of the company, and a special committee of independent directors unanimously approved the transaction, but the filing does not state the effect on future rental income or earnings.
Transaction closed July 1, 2026 at a total purchase price of $560 million for the property
Sold 35 facilities: 32 skilled nursing facilities and three independent living facilities
Master Lease terminated for all facilities except four Florida skilled nursing facilities, assigned to an NHC subsidiary
NHC owned 1,630,642 shares of the company's common stock as of December 31, 2025; a special committee of independent directors unanimously approved the deal
Apollo Global Management said preliminary estimates show alternative net investment income of approximately $350 million (pre-tax) for the quarter ended June 30, 2026, an estimated 9% annualized return on alternative net investments. The figures are unaudited and not yet final, and the full second-quarter earnings release is scheduled for August 4, 2026, so shareholders should wait for the final results before relying on these numbers.
Estimated alternative net investment income: approximately $350 million pre-tax for Q2 2026
Estimated annualized return on alternative net investments: 9%
Estimated pooled vehicle return of 10% and other alternative investments return of 6%, both for Q2 2026
Full Q2 earnings release and financial supplement scheduled for August 4, 2026; figures are unaudited and may change materially
On June 29, 2026, Avis Budget Group and subsidiaries Avis Budget Holdings, LLC and Avis Budget Car Rental, LLC entered an Eleventh Amendment to their Sixth Amended and Restated Credit Agreement with JPMorgan Chase Bank, N.A. as administrative agent. The amendment replaces the existing $2 billion revolving facility with a new $2 billion facility and adds a new $200 million revolving facility, both with springing maturities tied to other debt and legal settlement proceeds. The filing does not state pricing, drawn balances or the prior maturity date.
New $2 billion revolving facility (2031 Revolving Facility) matures June 29, 2031, with a springing maturity 90 days before certain long-term debt maturities if that debt exceeds $300 million
New $200 million revolving facility (2028 Revolving Facility) matures June 29, 2028
Amendment closed June 29, 2026; the 8-K was filed July 1, 2026 with the agreement attached as Exhibit 10.1
On June 29, 2026, Mama's Creations agreed to sell 5,555,556 shares of common stock at $18.00 each, with gross proceeds of approximately $100 million before fees. The offering was completed July 1, 2026, with net proceeds of approximately $94.0 million, which the company intends to use for working capital, general corporate purposes and possibly acquisitions with no current agreements. New shares dilute existing holders, and the company's filing also updates risk factors on integrating the Crown I Carve Out Business.
5,555,556 shares sold at $18.00 per share; gross proceeds of approximately $100 million before fees.
Underwriters have a 30-day option to buy up to 833,333 more shares; full exercise would bring gross proceeds to about $115 million.
Offering completed July 1, 2026; net proceeds of approximately $94.0 million for working capital and general corporate purposes.
Risk factor update on integrating the Crown I Carve Out Business, acquired September 2, 2025.
American Eagle Outfitters said Michael Mathias will step down as Executive Vice President and Chief Financial Officer and become a non-officer Strategic Advisor to CEO Jay Schottenstein, effective August 3, 2026. Ravi Thanawala, formerly CFO and President, North America at Papa John's International, will succeed him as CFO on the same date. The company also reaffirmed its second quarter and full-year fiscal 2026 guidance, originally given May 28, 2026.
Ravi Thanawala becomes Executive Vice President and Chief Financial Officer effective August 3, 2026, succeeding Michael Mathias
Mathias serves as Strategic Advisor to the CEO through July 30, 2027, and will not be eligible for any fiscal 2027 annual bonus or new equity awards
Thanawala's offer letter provides a $1,000,000 base salary, a target bonus of 100% of eligible earnings, and a $1,000,000 sign-on cash bonus
The company reaffirmed second quarter and full-year fiscal 2026 guidance, first provided on May 28, 2026
On July 1, 2026, Qnity Electronics entered into Repricing Amendment No. 1 to its October 31, 2025 credit agreement with JPMorgan Chase Bank, N.A. The amendment lowers the interest margin on all $2,338,250,000 of outstanding term loans, and the company says other loan terms are not materially changed. Lower borrowing costs can help free cash for shareholders, though the filing does not quantify the savings.
All $2,338,250,000 of term loans outstanding before July 1, 2026 were repriced.
Term SOFR margin falls from 2.00% to 1.75%; Base Rate Loan margin falls from 1.00% to 0.75%.
A 1.00% premium applies to certain repricing-related prepayments or amendments through six months after the closing date.
Other terms, including maturity, security and covenants, are described as materially unchanged.
AMD's board approved higher base salaries for five executive team members, effective July 1, 2026, and set long-term equity awards to be granted on August 15, 2026. CEO Lisa Su's salary rises from $1,323,000 to $1,375,000, and her $36 million target award will be mostly performance-based, so the final share count depends on future shareholder return and earnings targets.
Base salaries rise effective July 1, 2026; Lisa Su goes from $1,323,000 to $1,375,000 and Jean Hu from $800,000 to $850,000
Long-term awards with target values of $36 million for Su, $9 million for Hu, $10 million for Mark Papermaster, $7.5 million for Darren Grasby and $8 million for Forrest Norrod, granted August 15, 2026
Su's award is 75% performance-based restricted stock units (PRSUs) and 25% time-based RSUs; the others receive 60% PRSUs and 40% RSUs
PRSUs can pay out from 0% to 250% of target, based on relative total shareholder return over August 15, 2026 to August 15, 2029 and fiscal 2028 non-GAAP EPS against the fiscal 2026 target
Greenbrier reported fiscal third-quarter revenue of $576.5 million, down from $842.7 million a year earlier, and net earnings attributable to Greenbrier of $18.9 million, or $0.60 per diluted share, compared with $60.1 million a year earlier. The company narrowed its fiscal 2026 EPS guidance to $3.00 to $3.15 from $3.00 to $3.50 and lowered its aggregate gross margin guidance to 13.8% to 14.2%, which weighs on shareholders' expected earnings.
Q3 revenue of $576.5 million versus $842.7 million in the year-earlier quarter and $587.5 million in the prior quarter
Diluted EPS of $0.60 versus $1.86 a year earlier and $0.47 in the prior quarter
FY26 EPS guidance lowered to $3.00 to $3.15 from $3.00 to $3.50; aggregate gross margin guidance cut to 13.8% to 14.2% from 14.8% to 15.2%; revenue guidance unchanged at $2.4 billion to $2.5 billion
Quarterly dividend of $0.34 per share, payable August 6, 2026, to shareholders of record as of July 16, 2026
AppFolio announced that long-time chairman Andreas von Blottnitz and director Janet Kerr retired from the board effective June 29, 2026, and that two new independent directors, Diya Jolly and Michael Yang, were elected to fill the vacancies. The board also named CEO Shane Trigg as chairman, created a Lead Independent Director role held by Winifred Webb, and revised non-employee director pay. The filing does not discuss financial results, and the changes are governance updates rather than a financial event.
Andreas von Blottnitz (director since 2007) and Janet Kerr (director since 2015) retired effective June 29, 2026; the company says neither retirement involved a disagreement.
Shane Trigg, President and CEO, was appointed Chairman of the Board, succeeding Mr. von Blottnitz; he receives no separate pay for the role.
Winifred Webb was appointed Lead Independent Director; the annual cash retainer for that role is $40,000.
Non-employee director annual equity award rises to $200,000 from $150,000; Committee Chair retainer falls to $40,000 from $50,000.
On June 30, 2026, Evergy and three utility subsidiaries entered a credit agreement allowing up to $3.5 billion in aggregate borrowings, maturing June 30, 2031. The same day, they terminated a $2.5 billion credit agreement due August 31, 2028 and a $1 billion delayed draw term loan due August 10, 2026, with no early termination penalties. The filing does not state borrowing costs, so the financial effect for shareholders is not quantified beyond the facility size and terms.
Credit facility allows maximum borrowings of up to $3.5 billion, with sublimits of $200 million for letters of credit and $250 million for swingline loans
Matures June 30, 2031; borrowers may extend on up to two occasions for one-year terms and may increase commitments by up to $1 billion
Terminated the $2.5 billion credit agreement dated August 31, 2021 and the $1 billion delayed draw term loan dated May 5, 2026, with no early termination penalties
Marchex completed its acquisition of 100% of Archenia, Inc., a performance-based marketing technology company, on July 1, 2026. Stockholders approved the deal at a special meeting on the same day, with about 99.9% approval under both the simple majority and majority-of-the-minority votes. The company issued $10 million in 6% convertible notes to the sellers, and may issue additional shares if Archenia meets revenue, Adjusted EBITDA and integration targets.
Acquisition closed July 1, 2026; Archenia is a performance-based marketing technology company.
Company issued $10 million of convertible promissory notes bearing 6% interest, payable in three equal tranches at 12, 18 and 24 months after closing.
Notes convert into Class B common stock at $1.80 per share.
Earn-out of 2 million Class B shares for each of the first two 12-month periods, subject to revenue or Adjusted EBITDA growth and integration or customer retention targets.
Resideo's Board formally approved the planned spin-off of its ADI Global Distribution business, with a distribution date of August 3, 2026. Resideo shareholders are expected to receive one ADI share for every two Resideo shares held at the July 20 record date. To help finance the spin-off, ADI completed a $400 million senior notes offering and entered into a $600 million term loan and $500 million revolving credit facility.
Record date July 20, 2026; distribution date August 3, 2026, at 5:00 p.m. ET
Distribution ratio of one ADI share for every two Resideo shares held at the record date
ADI expected to trade on the NYSE as ADIG starting August 4, 2026; Resideo continues to trade as REZI
$400 million 7.125% senior notes due July 15, 2034, closed June 30, 2026; $600 million term loan and $500 million revolver entered July 1, 2026
Rigel Pharmaceuticals appointed director Alison L. Hannah, M.D. as Executive Vice President and Chief Medical Officer effective July 1, 2026, and she resigned from the Board at the same time. The filing also says Lisa Rojkjaer, M.D. left the Chief Medical Officer role and the company effective June 25, 2026, so the change is a leadership transition in a key clinical position.
Alison L. Hannah, M.D. appointed Executive Vice President and Chief Medical Officer on July 1, 2026
Dr. Hannah resigned from the Board of Directors effective July 1, 2026; she had served on the Board since May 2021
Lisa Rojkjaer, M.D. ceased to be Executive Vice President and Chief Medical Officer and separated from the company effective June 25, 2026
Dole plc said on July 1, 2026 that it closed the sale of its port and port operations in Guayaquil, Ecuador, first agreed in December 2025. The sale brings in net cash proceeds of approximately $75 million after costs and customary completion adjustments. The filing gives no figures on how the sale affects Dole's earnings or guidance.
Agreements to sell 100% of the membership interests in the Ecuadorian Port Business were signed December 13, 2025.
The transaction closed July 1, 2026, for net cash proceeds of approximately $75.0 million.
The filing names the buyer as Terminal Investment Limited Holding S.A., while the press release names TIL Switzerland Sàrl.
Biogen said its second-quarter 2026 GAAP and non-GAAP results will include about $164 million in pre-tax acquired in-process R&D, upfront and milestone expense, reducing diluted earnings per share by about $0.95. It also expects third-quarter charges of $290 million to $320 million, or $1.75 to $1.95 per diluted share, tied to potential milestones and transactions that have not yet closed. Shareholders face lower reported earnings in both quarters, and the second-quarter figures are preliminary.
Q2 2026 acquired IPR&D, upfront and milestone expense: about $164 million pre-tax, about $0.95 per diluted share
Q3 2026 expected expense: $290 million to $320 million, about $1.75 to $1.95 per diluted share
Q3 estimate relates to potential milestones and transactions that have not yet closed
Quarter ended June 30, 2026 results have not been finalized and may differ from these estimates
Zumiez Inc. said its Chief Financial Officer, Christopher C. Work, gave notice on June 30, 2026 that he will step down. Mr. Work will remain in the role and help with the transition until a successor is appointed, and the company has hired an executive search firm to find a new CFO.
CFO Christopher C. Work gave notice of his decision to step down on June 30, 2026.
Mr. Work served the company for 19 years and will continue as CFO during the transition.
The company has started a search for a new CFO and engaged a leading executive search firm.
Scotts Miracle-Gro's board named Nathan E. Baxter president and chief executive officer, effective June 26, 2026, and elected him to the board. Jim Hagedorn, CEO since 2001 and chairman since 2003, resigned from the board, and Lead Independent Director Peter Shumlin was elected chairman. The company reaffirmed its fiscal 2026 guidance in the same announcement.
Nathan E. (Nate) Baxter, 53, has been president and chief operating officer since November 2024; his base salary is $1,100,000 with a 150% target incentive.
Baxter will receive a true-up restricted stock unit grant with a grant date value of $2,000,000, and an annual long-term incentive target of $5,250,000 for the upcoming fiscal year.
Hagedorn's separation payment is $17,400,000, reduced by the value of his accrued pension benefit and paid over twelve months, plus $500,000 in aircraft-related services and $150,000 for administrative support.
The company reaffirmed fiscal 2026 guidance, including non-GAAP adjusted net income per share from continuing operations of $4.15 to $4.35.
Flexible Solutions International signed an at-the-market sales agreement with Bancroft Capital on June 30, 2026, allowing it to sell common stock worth up to $18.5 million through the agent. The company will pay Bancroft a 3% cash fee on gross proceeds, plus expense reimbursement up to $30,000 and up to $5,000 per quarter, so new shares could dilute existing holders.
Agreement dated June 30, 2026, with Bancroft Capital, LLC as sales agent for up to $18,500,000 of common stock
Shares sold under effective Form S-3 (Registration No. 333-293705), declared effective March 5, 2026
Cash fee of 3% of gross proceeds, plus expense reimbursement up to $30,000 and up to $5,000 per quarter
REX American Resources disclosed new employment agreements with Executive Chairman Stuart A. Rose, CEO Zafar A. Rizvi, and CFO Douglas L. Bruggeman, executed June 29, 2026 and effective February 1, 2026. The agreements raise maximum annual bonuses and maximum severance-related bonuses for all three executives, which increases potential compensation costs for shareholders.
Rizvi's annual maximum bonus rises from $5,000,000 to $12,000,000; his maximum termination bonus rises from $6,000,000 to $12,000,000.
Rose's annual maximum bonus rises from $2,500,000 to $4,000,000; his maximum termination bonus rises from $3,000,000 to $5,000,000.
Bruggeman's annual maximum bonus rises from $2,500,000 to $4,000,000; his maximum termination bonus rises from $3,000,000 to $5,000,000.
Base salaries are $225,000 for Rose, $275,000 for Rizvi and $300,000 for Bruggeman; the agreements supersede prior agreements.
Prologis, Inc. appointed Alfred F. Kelly, Jr. as a director on June 29, 2026, and announced it in a July 1, 2026 press release. The board determined Kelly is independent under NYSE and SEC rules, and he will join the Board Governance and Nomination Committee. The filing does not describe any financial results or changes to company operations.
Kelly was appointed to the board on June 29, 2026 and will join the Board Governance and Nomination Committee.
Kelly was chief executive officer of Visa Inc. from 2016 to 2023 and chairman of Visa's board from 2019.
He will receive compensation under Prologis' non-employee director program, as described in its 2026 proxy statement filed March 19, 2026.
CEO Dan Letter said Kelly's experience in technology, risk and global markets will be a valuable addition to the board.
Belden Inc. completed its acquisition of RUCKUS Networks from Vistance Networks on July 1, 2026, paying approximately $1.87 billion in cash, net of cash acquired and subject to post-closing adjustments. The purchase was funded in part by a $1,850.0 million senior secured term loan from a syndicate led by JPMorgan Chase Bank, N.A., which adds debt and limits the company's ability to incur more indebtedness and pay dividends.
Cash paid of approximately $1.87 billion, net of cash acquired, subject to customary post-closing adjustments
$1,850.0 million senior secured term loan, interest at term SOFR plus 2.25% or base rate plus 1.25%, maturing July 1, 2033
Loan amortizes 0.25% per quarter and is secured by substantially all assets of the company and guarantors
Financial statements and pro forma information to be filed under Form 8-K/A within 71 calendar days after the filing deadline
Omnicell appointed Nnamdi Njoku as President effective July 1, 2026, while he keeps his role as Chief Operating Officer. Randall Lipps stepped down as President but continues as Chief Executive Officer and Chairman, and Njoku will report to him. The filing describes this as a change in how Omnicell's top leadership duties are divided, with Njoku focused on long-term growth strategy and operational execution.
Njoku was appointed President effective July 1, 2026, and remains Chief Operating Officer; he had been COO since October 2024
Lipps stepped down as President; he remains CEO and Chairman with no compensation changes tied to the transition
Board approved a one-time restricted stock unit award with a target grant date value of approximately $500,000; one-third vests after one year, the rest in equal amounts at two and three years
Njoku's 2026 base salary is unchanged at $661,000, with a target cash bonus of 100% of base salary
Casella Waste Systems appointed Damian A. Ribar as executive vice president and chief operating officer, with employment expected to start July 20, 2026. He previously served as a division vice president at Waste Connections, most recently in North Florida, from August 2025 until July 2026.
Appointment approved by the Board on June 26, 2026; Ribar accepted the offer letter on June 27, 2026
Base salary of $500,000, with a cash bonus of up to 85% of base salary
Expected annual equity awards: restricted stock units with a $200,000 grant date value and performance stock units with a $600,000 grant date value
One-time option grant for 25,000 Class A shares, granted after second quarter 2026 earnings are announced
Enterprise Products Partners said co-chief executive Jim Teague intends to retire effective January 4, 2027, and its board elected co-chief executive Randy Fowler to become chief executive upon Teague's retirement. The filing describes an expanded Office of the Chairman that will include Fowler, Chief Commercial Officer Tug Hanley and Chief Financial Officer R. Daniel Boss, which sets out the leadership structure for the transition.
Jim Teague intends to retire effective January 4, 2027; he will be involved in transition activities over the next six months.
W. Randall Fowler, co-chief executive since January 2020, will become chief executive upon Teague's retirement.
Upon retirement, the Office of the Chairman will include Randa Duncan Williams, Hank Bachmann, Randy Fowler, Tug Hanley and R. Daniel Boss.
McKesson said Executive Vice President and Chief Strategy and Business Development Officer Thomas L. Rodgers, a named executive officer, gave notice on June 29, 2026 that he will retire, with his last day on August 1, 2026. The company said it appointed Ramesh Srinivasan as Executive Vice President, Chief Strategy Officer, effective August 1, 2026, to support an orderly transition.
Thomas L. Rodgers gave notice of retirement on June 29, 2026; his last day is August 1, 2026.
Ramesh Srinivasan appointed Executive Vice President, Chief Strategy Officer, effective August 1, 2026.
The filing contains no financial results, guidance or dollar figures.
UniFirst reported fiscal third-quarter 2026 results for the quarter ended May 30, 2026. Revenue rose 3.9% to $634.4 million, but net income fell to $19.9 million from $39.7 million, and diluted EPS was $1.09 versus $2.13, after about $20.7 million of costs tied to the pending Cintas merger. The company no longer provides financial guidance because of that pending transaction.
Revenue rose 3.9% to $634.4 million from $610.8 million a year earlier.
Net income was $19.9 million versus $39.7 million; diluted EPS was $1.09 versus $2.13.
About $20.7 million of Cintas merger-related transaction costs were included in the quarter's results.
The FTC issued a Second Request on June 11, 2026, and the transaction is expected to close in the second half of calendar 2026.
SiTime completed its acquisition of certain assets from Renesas Electronics, the timing business, and entered into a $200 million senior secured revolving credit facility with Wells Fargo as agent. The shares issued to Renesas are unregistered and carry registration rights, which could lead to future resales, and the company said the business is expected to generate at least $300 million in revenue in the 12 months after the acquisition.
Acquisition completed; the press release is dated July 1, 2026, and the asset purchase agreement was first filed on February 4, 2026
$200 million senior secured revolving credit facility dated June 30, 2026, with no loans outstanding as of the effective date
Shares issued to Renesas in a private placement; Renesas can request registration and underwritten offerings, with up to three underwritten offerings in any 18-month period
Hidetoshi Shibata, CEO of Renesas Electronics, is expected to join SiTime's board as a Class I director upon notice
On June 29, 2026, Vishay agreed to sell 15,000,000 common shares at $50.00 each, and underwriters exercised in full their option to buy 2,250,000 more on June 30. The company expects net proceeds of about $830.3 million, to be used for growth initiatives, general corporate purposes and reducing borrowings under its senior secured credit facility. The sale adds to the number of shares outstanding, and closing is expected on July 1, 2026.
15,000,000 shares offered at $50.00 per share, with J.P. Morgan Securities LLC as representative of the underwriters
Underwriters exercised in full their 30-day option for 2,250,000 additional shares on June 30, 2026
Expected net proceeds of about $830.3 million, to fund growth initiatives and reduce senior secured credit facility borrowings
Offering expected to close July 1, 2026, subject to customary closing conditions
On June 30, 2026, FTI Consulting entered into a Third Amendment and Restatement Agreement with a lender syndicate led by Bank of America, N.A. The revolving credit facility rises from $900.0 million to $1.5 billion, and its maturity moves from November 21, 2027 to June 30, 2031. The company says the changes give it more financial flexibility and better ratings-based pricing, which may matter to shareholders as added borrowing capacity and longer debt maturities.
Revolving facility increased from $900.0 million to $1.5 billion; obligations are unsecured and guaranteed by certain material wholly-owned domestic subsidiaries.
Maturity extended from November 21, 2027 to June 30, 2031.
Incremental facilities of up to the greater of $500.0 million and 100% of consolidated EBITDA are permitted, subject to a net leverage ratio of no more than 4.00 to 1.00.
The existing $300.0 million term loan, due March 17, 2029, remains outstanding under the new agreement.
Kimball Electronics completed its acquisition of Helvoet Polymer Technologies, a European contract development and manufacturing firm with operations in India, on July 1, 2026. The purchase price was €90 million, or about $103 million, funded with cash and existing credit lines. The company expects the deal to be accretive to fiscal 2027 adjusted earnings and to increase sales in its medical vertical by a low double-digit percentage.
Purchase price of €90 million (about $103 million), subject to post-closing working capital adjustments; €1.8 million held in escrow
Helvoet calendar 2025 revenue of approximately $56 million, with over 70% from medical customers
Price represents about 9x estimated Helvoet adjusted EBITDA for calendar 2026
Management webcast scheduled for Wednesday, July 1, 2026, at 9:00 AM ET
Prosperity Bancshares completed its acquisition of Stellar Bancorp on July 1, 2026, with Stellar merging into Prosperity and Stellar Bank merging into Prosperity Bank. Stellar holders received 0.3803 Prosperity shares plus $11.36 in cash per share, with total consideration of about $590 million in cash and 19 million Prosperity shares, and the filing notes Prosperity assumed about $2.17 billion in Federal Home Loan Bank of Dallas obligations.
Closing effective July 1, 2026; merger agreement dated January 27, 2026
Stellar holders received 0.3803 Prosperity shares and $11.36 cash per share; total consideration about $590 million cash and 19 million shares
Prosperity assumed about $2.17 billion in FHLB Dallas obligations issued to Stellar Bank
Robert R. Franklin, Jr. joined the board and became Vice Chairman; his agreement includes a $3,000,000 signing bonus and a 25,000-share restricted stock award
On June 26, 2026, Owlet and its subsidiary Owlet Baby Care entered a $25 million asset-based revolving credit facility with Wells Fargo, which refinanced the subsidiary's existing ABL line of credit and WTI term loan. The company's press release says the new margin of SOFR plus 2.00% to 2.25% is well below the previous SOFR plus 7.50% to 8.50%, and it reports total liquidity of about $33.8 million as of June 26, 2026. The facility is secured by substantially all personal property assets and guaranteed by Owlet, and it carries a $7.5 million minimum liquidity covenant and EBITDA thresholds.
New $25 million revolving facility with Wells Fargo dated June 26, 2026; can be increased to $35 million with lender approval
OBCI drew $17,063,000 on June 26, 2026 and used the proceeds to repay the ABL line of credit and WTI term loan
Margin falls to SOFR plus 2.00% to 2.25%, versus SOFR plus 7.50% to 8.50% on the previous ABL facility, per the press release
Facility matures on the third anniversary of June 26, 2026; requires at least $7.5 million of liquidity at all times
On June 30, 2026, FMC agreed to sell 30,319,166 shares of common stock to Tessenderlo Group NV at $13.30 per share, for an aggregate purchase price of $403,244,907.80, subject to customary conditions including regulatory approvals. After closing, Tessenderlo is expected to own about 20.0% of FMC's outstanding shares, up from less than 1.0% today, and FMC intends to use the proceeds to pay down debt toward its approximately $1 billion target.
30,319,166 shares sold at $13.30 each, for an aggregate $403,244,907.80, with closing subject to regulatory approvals
Tessenderlo expected to hold about 20.0% of outstanding shares after closing, versus less than 1.0% now
Investor agreement gives Tessenderlo one board seat while it holds at least 10.0%, and a 36-month lock-up on transfers
Proceeds go to debt paydown toward an approximately $1 billion target; FMC says this concludes its strategic options review announced in February 2026
FactSet reported results for its fiscal third quarter ended May 31, 2026, with revenue up 6.4% to $622.9 million while GAAP diluted EPS fell 9.6% to $3.50. Adjusted diluted EPS rose 6.1% to $4.53, but GAAP results absorbed restructuring, severance and CEO compensation costs. The company reaffirmed its fiscal 2026 outlook, so shareholders get a mixed quarter with no change to guidance.
Revenue was $622.9 million, up 6.4% from $585.5 million a year earlier; organic revenue rose 7.0%.
GAAP diluted EPS was $3.50 versus $3.87; adjusted diluted EPS was $4.53 versus $4.27.
Restructuring/severance charges of $19.6 million weighed on operating income; GAAP operating margin was 26.7% versus 33.2%.
Fiscal 2026 guidance was reaffirmed, including GAAP revenues of $2,450 million to $2,470 million and GAAP diluted EPS of $14.85 to $15.35.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Briefs marked “Written later” were written in November 2026 for filings that were by then more than three weeks old, so months before mid-October 2026 hold a selection: every material 8-K of the past year for the 100 largest companies we cover and the last 15 important 8-Ks of every other one. Briefs the number check holds back are not shown or counted. Also: the last 45 days, briefs by company, A–Z and the live SEC filings wire.